blood biomarkers
NeuroVision is developing proprietary blood tests that allow people to track levels of key neurological biomarkers in order to provide both feedback to clinicians and motivation to patients for lifestyle risk reduction that can potentially delay the onset of cognitive decline. NeuroVision works closely with pharmaceutical companies for potential complementary and companion biomarker opportunities.
Retinal AUTOFLUORESCENCE Imaging
NeuroVision has developed the Afina® system for the visualization and measurement of retinal autofluorescence. Protein deposits in the retina auto-emit light when excited by blue light. This fluorescence can be captured and measured using Afina. The enhance images and measurements produced by Afina can be used by doctors to better assess a variety of conditions that manifest in the retina. Published research has demonstrated that small AF spots in the retina may contain amyloid beta.1,2 Human cadaver studies have demonstrated correlation between the abundance of amyloid in the retina with amyloid abundance in the brain, which is the hallmark sign of AD.2,3
Retinal Image Analysis
NeuroVision is developing software intended for importing, processing and displaying of retinal images and for the measurement of ocular features in those images of the retina, with the goal of allowing doctors to practice best-in-class medicine through better identification and management of retinal diseases.
Fluid Biomarkers
NeuroVision is developing proprietary blood tests that allow people to track levels of key neurological biomarkers in order to provide both feedback to clinicians and motivation to patients for lifestyle risk reduction that can potentially delay the onset of cognitive decline. NeuroVision works closely with pharmaceutical companies for potential complementary and companion biomarker opportunities.
Retial Image Analysis
NeuroVision is developing an extension of Afina intended for importing, processing and displaying of retinal images and for the measurement of ocular features in those images of the retina, with the goal of allowing doctors to practice best-in-class medicine through better identification and management of retinal diseases.
Investigational Device. Limited by Federal (or United States) law to investigational use.